These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 17046652

  • 1. Proteomics of polyglutamine aggregates.
    Mitsui K, Doi H, Nukina N.
    Methods Enzymol; 2006; 412():63-76. PubMed ID: 17046652
    [Abstract] [Full Text] [Related]

  • 2. Purification of polyglutamine aggregates and identification of elongation factor-1alpha and heat shock protein 84 as aggregate-interacting proteins.
    Mitsui K, Nakayama H, Akagi T, Nekooki M, Ohtawa K, Takio K, Hashikawa T, Nukina N.
    J Neurosci; 2002 Nov 01; 22(21):9267-77. PubMed ID: 12417652
    [Abstract] [Full Text] [Related]

  • 3. Evidence for a recruitment and sequestration mechanism in Huntington's disease.
    Preisinger E, Jordan BM, Kazantsev A, Housman D.
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):1029-34. PubMed ID: 10434302
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates.
    Kotliarova S, Jana NR, Sakamoto N, Kurosawa M, Miyazaki H, Nekooki M, Doi H, Machida Y, Wong HK, Suzuki T, Uchikawa C, Kotliarov Y, Uchida K, Nagao Y, Nagaoka U, Tamaoka A, Oyanagi K, Oyama F, Nukina N.
    J Neurochem; 2005 May 29; 93(3):641-53. PubMed ID: 15836623
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells.
    Doi H, Okamura K, Bauer PO, Furukawa Y, Shimizu H, Kurosawa M, Machida Y, Miyazaki H, Mitsui K, Kuroiwa Y, Nukina N.
    J Biol Chem; 2008 Mar 07; 283(10):6489-500. PubMed ID: 18167354
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
    Banerjee M, Datta M, Bhattacharyya NP.
    Int J Biochem Cell Biol; 2017 Jan 07; 82():1-9. PubMed ID: 27840155
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Calmodulin regulates transglutaminase 2 cross-linking of huntingtin.
    Zainelli GM, Ross CA, Troncoso JC, Fitzgerald JK, Muma NA.
    J Neurosci; 2004 Feb 25; 24(8):1954-61. PubMed ID: 14985437
    [Abstract] [Full Text] [Related]

  • 16. Nuclear targeting of mutant Huntingtin increases toxicity.
    Peters MF, Nucifora FC, Kushi J, Seaman HC, Cooper JK, Herring WJ, Dawson VL, Dawson TM, Ross CA.
    Mol Cell Neurosci; 1999 Aug 25; 14(2):121-8. PubMed ID: 10479410
    [Abstract] [Full Text] [Related]

  • 17. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein.
    Jiang H, Nucifora FC, Ross CA, DeFranco DB.
    Hum Mol Genet; 2003 Jan 01; 12(1):1-12. PubMed ID: 12490527
    [Abstract] [Full Text] [Related]

  • 18. Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington's Disease: Background and Evaluation in Cell Culture.
    Zhang X, Abels ER, Redzic JS, Margulis J, Finkbeiner S, Breakefield XO.
    Cell Mol Neurobiol; 2016 Apr 01; 36(3):459-70. PubMed ID: 26951563
    [Abstract] [Full Text] [Related]

  • 19. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH, Charles V, Williams M, Miller G, Whetsell WO, Tagle DA.
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):1035-45. PubMed ID: 10434303
    [Abstract] [Full Text] [Related]

  • 20. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
    Wyttenbach A, Swartz J, Kita H, Thykjaer T, Carmichael J, Bradley J, Brown R, Maxwell M, Schapira A, Orntoft TF, Kato K, Rubinsztein DC.
    Hum Mol Genet; 2001 Aug 15; 10(17):1829-45. PubMed ID: 11532992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.